Michihiko Sone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michihiko Sone has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
Tsutomu Nakashima
Department of Otorhinolaryngology, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi 474-8511, Japan
21 shared publications- Shinji Naganawa
Department of Radiology, Nagoya University Graduate School of Medicine, Japan
14 shared publications Tadao Yoshida
Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
9 shared publications- Tadao Yoshida
Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
9 shared publications Masaaki Teranishi
Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
8 shared publications- Tsutomu Nakashima
Department of Rehabilitation, Ichinomiya Medical Treatment & Habilitation Center, Ichinomiya, Japan
7 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (5) , 725-729
The laryngofissure approach for near-infrared photoimmunotherapy in laryngeal cancer: A novel larynx-preservation strategy
- 17 July 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (5) , 725-729
Open AccessThe laryngofissure approach for near-infrared photoimmunotherapy in laryngeal cancer: A novel larynx-preservation strategy
- Open Access
- 1 April 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (3) , 375-379
Successful management of near-infrared photoimmunotherapy-induced skin injury using pedicled flap transfer
- 1 April 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (3) , 375-379
Open AccessSuccessful management of near-infrared photoimmunotherapy-induced skin injury using pedicled flap transfer
- 8 January 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (1) , 99-106
Three-dimensional analysis of vocal fold nodules in operatic soprano singers undergoing microlaryngeal surgery: Differences according to voice type subcategories (Lyric vs. Dramatic)
- 8 January 2026
- Published by Elsevier in Auris Nasus Larynx
- Vol. 53 (1) , 99-106
Three-dimensional analysis of vocal fold nodules in operatic soprano singers undergoing microlaryngeal surgery: Differences according to voice type subcategories (Lyric vs. Dramatic)
- Open Access
- 30 July 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (4) , 527-530
New evaluation method using sound stimulation for asymptomatic vestibular dysfunction
- 30 July 2025
- Published by Elsevier in Auris Nasus Larynx
- Vol. 52 (4) , 527-530
Open AccessNew evaluation method using sound stimulation for asymptomatic vestibular dysfunction
- Open Access
- 4 March 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (2) , e70109
Anxiety, Depression and Cancer‐Related Post‐Traumatic Stress in Patients Undergoing Total Laryngectomy
Purpose: This study aims to elucidate the incidence of cancer‐related post‐traumatic stress (PTS) and the fluctuations in anxiety and depression levels before and one year after laryngectomy.Methods: A prospective longitudinal study was conducted on 97 consecutive patients scheduled to undergo laryngectomy (total laryngectomy or pharyngolaryngectomy) at a single university hospital between 2007 and 2022. To assess cancer‐related PTS, anxiety, and depression, participants completed two brief self‐reported questionnaires: the Impact of Event Scale‐Revised (IES‐R) and the Hospital Anxiety and Depression Scale (HADS).Results: Prior to laryngectomy, 32 patients planning for the procedure were considered as cancer‐related PTS based on IES‐R. The prevalence of anxiety and depression before surgery was 56% and 76% in the 32 patients with PTS, respectively, compared to 8% and 20% in the 65 patients without PTS. Patients with PTS exhibited significantly worse HADS‐anxiety and HADS‐depression scores compared to those without PTS at baseline (p < 0.001 for both). Although no significant difference was found in the HADS‐anxiety score between the two groups (p = 0.15), patients with PTS exhibited a significantly worse HADS‐depression score than those without PTS one year after surgery (p = 0.03).Conclusion: Early identification of possible depressive disorders and active psychiatric interventions are crucial for patients undergoing laryngectomy during the follow‐up period. Preoperative assessment of cancer‐related PTS may offer an opportunity to implement appropriate psychological interventions.Level of Evidence: 4.
- 4 March 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (2) , e70109
Open AccessAnxiety, Depression and Cancer‐Related Post‐Traumatic Stress in Patients Undergoing Total Laryngectomy
Purpose: This study aims to elucidate the incidence of cancer‐related post‐traumatic stress (PTS) and the fluctuations in anxiety and depression levels before and one year after laryngectomy.Methods: A prospective longitudinal study was conducted on 97 consecutive patients scheduled to undergo laryngectomy (total laryngectomy or pharyngolaryngectomy) at a single university hospital between 2007 and 2022. To assess cancer‐related PTS, anxiety, and depression, participants completed two brief self‐reported questionnaires: the Impact of Event Scale‐Revised (IES‐R) and the Hospital Anxiety and Depression Scale (HADS).Results: Prior to laryngectomy, 32 patients planning for the procedure were considered as cancer‐related PTS based on IES‐R. The prevalence of anxiety and depression before surgery was 56% and 76% in the 32 patients with PTS, respectively, compared to 8% and 20% in the 65 patients without PTS. Patients with PTS exhibited significantly worse HADS‐anxiety and HADS‐depression scores compared to those without PTS at baseline (p < 0.001 for both). Although no significant difference was found in the HADS‐anxiety score between the two groups (p = 0.15), patients with PTS exhibited a significantly worse HADS‐depression score than those without PTS one year after surgery (p = 0.03).Conclusion: Early identification of possible depressive disorders and active psychiatric interventions are crucial for patients undergoing laryngectomy during the follow‐up period. Preoperative assessment of cancer‐related PTS may offer an opportunity to implement appropriate psychological interventions.Level of Evidence: 4.
- Open Access
- 21 January 2025
- Published by Elsevier in Neuroscience Research
- Vol. 213, 23-34
Loss of neuronal activity facilitates surface accumulation of p75NTR and cell death in avian cochlear nucleus
- 21 January 2025
- Published by Elsevier in Neuroscience Research
- Vol. 213, 23-34
Open AccessLoss of neuronal activity facilitates surface accumulation of p75NTR and cell death in avian cochlear nucleus
- Open Access
- 12 October 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (5) , e1312
Perilymphatic enhancement and endolymphatic hydrops: MRI findings and clinical associations
Objective: In this study, we aimed to summarize magnetic resonance imaging (MRI) findings of perilymphatic enhancement (PE) and endolymphatic hydrops (EH) of the inner ear, which are associated with vestibular and cochlear symptoms.Methods: We analyzed data on ears with definite Meniere's disease (MD), sensorineural hearing loss (SNHL), vertigo, and listening difficulties (LiD) from 508 ears of 254 patients who underwent contrast‐enhanced 3‐Tesla MRI between April 2021 and March 2023. We evaluated the degree of endolymphatic hydrops (EH), signal intensity ratios (SIRs) between the basal turns of the cochlea and cerebellum, and hearing levels for all ears. Ears with definite MD were also assessed for changes in vestibular and cochlear symptoms within 6 months.Results: Ears with definite MD exhibited significantly higher percentages of EH in both the vestibule and cochlea compared with ears with other diseases. Furthermore, ears with MD or sensorineural hearing loss (SNHL) had significantly higher SIRs of PE compared with ears with other diseases or asymptomatic ears. Among patients with definite MD, those experiencing hearing fluctuations or vertigo attacks within the last 6 months had significantly higher SIRs of PE compared with those who did not experience any symptoms.Conclusion: Significant EH in the vestibule and cochlea was a major finding for the imaging diagnosis of definite MD. A high SIR of PE was a good indicator for assessing MD activity, reflecting vestibular and cochlear symptoms and fluctuations.Level of Evidence: 4.
- 12 October 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (5) , e1312
Open AccessPerilymphatic enhancement and endolymphatic hydrops: MRI findings and clinical associations
Objective: In this study, we aimed to summarize magnetic resonance imaging (MRI) findings of perilymphatic enhancement (PE) and endolymphatic hydrops (EH) of the inner ear, which are associated with vestibular and cochlear symptoms.Methods: We analyzed data on ears with definite Meniere's disease (MD), sensorineural hearing loss (SNHL), vertigo, and listening difficulties (LiD) from 508 ears of 254 patients who underwent contrast‐enhanced 3‐Tesla MRI between April 2021 and March 2023. We evaluated the degree of endolymphatic hydrops (EH), signal intensity ratios (SIRs) between the basal turns of the cochlea and cerebellum, and hearing levels for all ears. Ears with definite MD were also assessed for changes in vestibular and cochlear symptoms within 6 months.Results: Ears with definite MD exhibited significantly higher percentages of EH in both the vestibule and cochlea compared with ears with other diseases. Furthermore, ears with MD or sensorineural hearing loss (SNHL) had significantly higher SIRs of PE compared with ears with other diseases or asymptomatic ears. Among patients with definite MD, those experiencing hearing fluctuations or vertigo attacks within the last 6 months had significantly higher SIRs of PE compared with those who did not experience any symptoms.Conclusion: Significant EH in the vestibule and cochlea was a major finding for the imaging diagnosis of definite MD. A high SIR of PE was a good indicator for assessing MD activity, reflecting vestibular and cochlear symptoms and fluctuations.Level of Evidence: 4.
- 2 April 2024
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 144 (4) , 272-276
Efficacy of 100 hz sound stimulation on saccular dysfunction in meniere’s disease
Although various medical remedies have been attempted to alleviate the symptoms of Meniere's disease (MD), the risk-benefit ratios of these various treatments remain debatable. We investigated the efficacy of sound stimulation of 100 Hz for treating vestibular dysfunction in patients with Meniere's disease (MD). Patients with definitive MD with intractable vestibular symptoms and endolymphatic hydrops (EH) in the inner ear were evaluated. The experimental group received sound stimulation of 75 dB at a frequency of 100 Hz for 5 min, and the control group received sound stimulation of 75 dB at a frequency of 250 Hz for 5 min. Cervical vestibular-evoked myogenic potentials (cVEMPs) were measured before and after each sound stimulation, and the results of the clinical tests were compared between the two patient groups. Significant increases in cVEMP amplitudes were observed after sound stimulation of 100 Hz in ears with vestibular endolymphatic hydrops, although no such improvement was observed in the control group. Sound stimulation of 75 dB at a frequency of 100 Hz leads to improvement in cVEMP amplitude in patients with definitive MD. Adequate sound stimulation might be a new method for treating vestibular dysfunction associated with MD.
- 2 April 2024
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 144 (4) , 272-276
Efficacy of 100 hz sound stimulation on saccular dysfunction in meniere’s disease
Although various medical remedies have been attempted to alleviate the symptoms of Meniere's disease (MD), the risk-benefit ratios of these various treatments remain debatable. We investigated the efficacy of sound stimulation of 100 Hz for treating vestibular dysfunction in patients with Meniere's disease (MD). Patients with definitive MD with intractable vestibular symptoms and endolymphatic hydrops (EH) in the inner ear were evaluated. The experimental group received sound stimulation of 75 dB at a frequency of 100 Hz for 5 min, and the control group received sound stimulation of 75 dB at a frequency of 250 Hz for 5 min. Cervical vestibular-evoked myogenic potentials (cVEMPs) were measured before and after each sound stimulation, and the results of the clinical tests were compared between the two patient groups. Significant increases in cVEMP amplitudes were observed after sound stimulation of 100 Hz in ears with vestibular endolymphatic hydrops, although no such improvement was observed in the control group. Sound stimulation of 75 dB at a frequency of 100 Hz leads to improvement in cVEMP amplitude in patients with definitive MD. Adequate sound stimulation might be a new method for treating vestibular dysfunction associated with MD.
- Open Access
- 8 January 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (1) , e1210
Improvement of vertigo symptoms and acoustic power absorbance in cases with endolymphatic hydrops
Objective: The pathophysiology and symptoms underlying Meniere's disease (MD) manifest as endolymphatic hydrops (EH), potentially impacting acoustic power absorbance in vestibular EH. The longitudinal effects of middle ear pressure therapy (MEPT) and conservative therapies for EH by magnetic resonance imaging (MRI) and on acoustic power absorbance on wideband acoustic immittance (WAI) were evaluated, and their changes were compared with clinical symptoms.Methods: Eleven patients with definite MD or delayed endolymphatic hydrops (DEH), resistant to conservative therapies and who continued MEPT for 1 year, were included. Vertigo scores, hearing levels, acoustic power absorbance on WAI, and degrees of EH on 3‐T MRI were evaluated and compared before and after the treatments.Results: One year after the start of MEPT, all cases showed symptomatic improvement in vertigo score; however, the degrees of EH showed no improvements except in one case. In the affected ears with EH, their absorbances on WAI improved, particularly at 1580–1905 or 2400–2953 Hz (p < .05).Conclusion: Alleviation of vestibular symptoms with the therapy of MD was not necessarily associated with improved EH. Vestibular symptoms could be related to the change in the impedance of inner ear pressure, which was proven by the normalization of acoustic power absorbance. Assessments of acoustic power absorbance may provide useful information for physiological conditions and causative factors of vertigo in ears with EH.Level of evidence: 4
- 8 January 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (1) , e1210
Open AccessImprovement of vertigo symptoms and acoustic power absorbance in cases with endolymphatic hydrops
Objective: The pathophysiology and symptoms underlying Meniere's disease (MD) manifest as endolymphatic hydrops (EH), potentially impacting acoustic power absorbance in vestibular EH. The longitudinal effects of middle ear pressure therapy (MEPT) and conservative therapies for EH by magnetic resonance imaging (MRI) and on acoustic power absorbance on wideband acoustic immittance (WAI) were evaluated, and their changes were compared with clinical symptoms.Methods: Eleven patients with definite MD or delayed endolymphatic hydrops (DEH), resistant to conservative therapies and who continued MEPT for 1 year, were included. Vertigo scores, hearing levels, acoustic power absorbance on WAI, and degrees of EH on 3‐T MRI were evaluated and compared before and after the treatments.Results: One year after the start of MEPT, all cases showed symptomatic improvement in vertigo score; however, the degrees of EH showed no improvements except in one case. In the affected ears with EH, their absorbances on WAI improved, particularly at 1580–1905 or 2400–2953 Hz (p < .05).Conclusion: Alleviation of vestibular symptoms with the therapy of MD was not necessarily associated with improved EH. Vestibular symptoms could be related to the change in the impedance of inner ear pressure, which was proven by the normalization of acoustic power absorbance. Assessments of acoustic power absorbance may provide useful information for physiological conditions and causative factors of vertigo in ears with EH.Level of evidence: 4
- Open Access
- 27 July 2023
- Published by MDPI AG in Audiology Research
- Vol. 13 (4) , 563-572
Comparative Analysis of Cartilage Conduction Hearing Aid Users and Non-Users: An Investigative Study
Clinical findings on cartilage conduction hearing aids (CCHAs) have gradually become clear; however, few reports include a large number of cases. This study included 91 ears from 69 patients who underwent CCHA fitting in our hospital. Their ears were divided into six groups (i.e., bilateral aural atresia or severe canal stenosis, unilateral aural atresia or severe canal stenosis, chronic otitis media or chronic otitis externa with otorrhea, sensorineural hearing loss, mixed hearing loss, and conductive hearing loss) according to their clinical diagnosis and type of hearing loss. Most clinical diagnoses were aural atresia or meatal stenosis (bilateral, 21.8%; unilateral, 39.6%). The purchase rate of CCHAs was higher in the closed-ear group (bilateral, 77.3%; unilateral, 62.5%). In the bilateral closed-ear group, air conduction thresholds at 1000, 2000, and 4000 Hz and aided thresholds with CCHAs at 4000 Hz were significantly lower in the purchase group than the non-purchase group. No significant difference was observed between the purchase and non-purchase groups in the unilateral closed-ear group. In the bilateral closed-ear group, air conduction thresholds and aided thresholds were associated with the purchase rate of CCHAs. In the unilateral closed-ear group, factors other than hearing might have affected the purchase rate of CCHAs.
- 27 July 2023
- Published by MDPI AG in Audiology Research
- Vol. 13 (4) , 563-572
Open AccessComparative Analysis of Cartilage Conduction Hearing Aid Users and Non-Users: An Investigative Study
Clinical findings on cartilage conduction hearing aids (CCHAs) have gradually become clear; however, few reports include a large number of cases. This study included 91 ears from 69 patients who underwent CCHA fitting in our hospital. Their ears were divided into six groups (i.e., bilateral aural atresia or severe canal stenosis, unilateral aural atresia or severe canal stenosis, chronic otitis media or chronic otitis externa with otorrhea, sensorineural hearing loss, mixed hearing loss, and conductive hearing loss) according to their clinical diagnosis and type of hearing loss. Most clinical diagnoses were aural atresia or meatal stenosis (bilateral, 21.8%; unilateral, 39.6%). The purchase rate of CCHAs was higher in the closed-ear group (bilateral, 77.3%; unilateral, 62.5%). In the bilateral closed-ear group, air conduction thresholds at 1000, 2000, and 4000 Hz and aided thresholds with CCHAs at 4000 Hz were significantly lower in the purchase group than the non-purchase group. No significant difference was observed between the purchase and non-purchase groups in the unilateral closed-ear group. In the bilateral closed-ear group, air conduction thresholds and aided thresholds were associated with the purchase rate of CCHAs. In the unilateral closed-ear group, factors other than hearing might have affected the purchase rate of CCHAs.